The need for regulation of dietary supplements - Lessons from ephedra

被引：69

作者：

Fontanarosa, PB ^{[1
]}

Rennie, D ^{[1
]}

DeAngelis, CD ^{[1
]}

机构：

[1] JAMA, Chicago, IL 60610 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 289卷 / 12期

关键词：

D O I：

10.1001/jama.289.12.1568

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1568 / 1570

页数：3

共 13 条

[1]

BENT S, 2003, ANN INTERN MED

[2] Severe hepatotoxicity associated with the dietary supplement LipoKinetix [J].

Favreau, JT ;

Ryu, ML ;

Braunstein, G ;

Orshansky, G ;

Park, SS ;

Coody, GL ;

Love, LA ;

Fong, TL .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (08) :590-595

[3]

Federal Trade Commission (FTC), DIET SUPPL ADV GUID

[4] Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. [J].

Haller, CA ;

Benowitz, NL .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1833-1838

[5]

HOFFMAN BB, 2001, GOODMAN GILMANS PHAR

[6] Balancing safety of dietary supplements with the free market [J].

Lewis, JD ;

Strom, BL .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (08) :616-618

[7]

Office of Inspector General, 2001, ADV EV REP DIET SUPP

[8]

Shekelle P, 2003, AHRQ PUBLICATION, V03-E023

[9] Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance -: A meta-analysis [J].

Shekelle, PG ;

Hardy, ML ;

Morton, SC ;

Maglione, M ;

Mojica, WA ;

Suttorp, MJ ;

Rhodes, SL ;

Jungvig, L ;

Gagné, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (12) :1537-1545

[10]

*US FDA, EV SAF EFF EPH IMPL

← 1 2 →